David Phoenix

  (Redirected from David Andrew Phoenix)

David Andrew Phoenix OBE DL FRSC FAcSS (born 1966) is an English biochemist and Chief Executive of London South Bank University.[1][2]

David Phoenix

David Andrew Phoenix

(1966-02-26) 26 February 1966 (age 54)
Davyhulme, Greater Manchester, England
Alma materUniversity of Liverpool
Open University
Known forPeptide-lipid interaction; function of antibacterial peptides
AwardsOrder of the British Empire 2010
Academician, Academy of Social Sciences 2012
Deputy Lieutenant 2015
Friendship Award (China) 2016
Scientific career
FieldsBiochemistry/Biophysics/Molecular engineering
InstitutionsUniversity of Liverpool
University of Utrecht
University of Central Lancashire

Early lifeEdit

Phoenix was born on 26 February 1966 in Greater Manchester, England. After attending Turton High school in Bolton he studied Biochemistry at Liverpool University and graduated BSc. He remained at Liverpool to complete his doctorate on penicillin binding proteins.


After postdoctoral work in England and the Netherlands, he began work at the University of Central Lancashire where he became Deputy Vice-Chancellor before being appointed as Vice-Chancellor and Chief Executive of London South Bank University.[3][4]

Academic backgroundEdit

Phoenix read biochemistry and obtained his BSc degree from the University of Liverpool followed by completion of a doctorate, in biochemistry. He continued to study part-time and obtained a Bachelor of Arts degree from the Open University in mathematics. Further study generated a master's degree in education and later a master's degree in business administration. His contribution to the field of biochemistry was rewarded by the presentation of the degree of Doctor of Science from Liverpool University. This higher doctorate recognised his work into the importance of amphiphilicity in the localisation and function of bioactive molecules.

He has published widely on the structure-function relationship of amphiphilic biomolecules,[5] obtaining a Chair in Biochemistry in 2000. He has held Visiting Chairs in Russia, China, and Canada. In addition to peer-reviewed papers, edited collections and research monographs he has also been recognised for publication of undergraduate textbooks. And has been Editor in Chief for journals focused on education and for periodicals such as Biologist which are aimed at a broader readership.


The group is multidisciplinary and draws on a range of specialties including, biology, chemistry, engineering, physics and computational modelling to help develop understanding of the structure function relationships used by amphiphilic bioactive molecules.[6] The term ‘‘peptide-amphiphile’’ can be used to describe amphiphilic peptides consisting only of amino acids that show segregation of charged and uncharged components within the primary or secondary structure. Alternatively, they may be composed of hydrophilic peptides linked to hydrophobic alkyl chains or lipids, and peptide-based copolymers. Such molecules are of significant biological importance due to the range of asymmetric boundaries that occur in nature such as those found at a membrane lipid interface. Amphiphilic protein sequences can be involved in protein targeting, membrane protein assembly as well as membrane fusion and lysis. In addition to amphiphilic peptides possessing key biological functions amphiphiles are becoming of increasing interest in the creation of new biomaterials. Amphiphiles can self-assemble into a variety of different structures such as micelles, vesicles, monolayers, bilayers, nanofibers, nanotapes, ribbons, and twisted ribbons, to minimise unfavorable interactions with their surroundings. A key aspect of his work involves the development of bioactive peptides and new biomaterials with biomedical application.

Significant awardsEdit

Professional recognitionEdit

He was granted Chartered Chemist status by the Royal Society of Chemistry in the UK and later made a Fellow of the Society (FRSC). In addition, he was recognised as a Chartered Biologist and became a Fellow of the Institute of Biology, (FIBiol). He also became recognised as a Chartered Mathematician and later advanced to Fellowship of the Institute of Mathematics and its Applications. In 2007 he was recognised as a Fellow of the Royal Society of Medicine. In 2008 his work in support of teaching was recognised by the award of a Senior Fellowship[9] by the Higher Education Academy and later advanced to Principal Fellow

Career historyEdit

His PhD work engaged his interest in the role amphiphilicity plays in driving the interaction of bioactive molecules with cell membranes. He was awarded a long-term fellowship by the European Molecular Biology Organisation which enabled him to investigate the importance of amphiphilicity in protein translocation at Utrecht University Centre for Biomembranes and Lipid Enzymology. He continued to work on amphiphilic helices, being one of the first to help characterise their role as membrane protein anchors. He later expanded this work to investigate the importance of structure-function relationships in the design of antimicrobial peptides.

In 2000 he launched a new Department of Forensic and Investigative Science at the University of Central Lancashire and in 2002 he became Dean of Science and Technology when he launched a new School of Pharmacy. During this time he also remained the UK representative on the European Committee of Biological Associations (ECBA) and for a while was a Commissioner for Biotechnology. He remains an international advisor on higher education and science to the University of Guyana.

In 2008 he became Deputy Vice-Chancellor with responsibility for strategic planning and performance across the University of Central Lancashire group. In 2010 he created UCLan Biomedical Technology Ltd, a research institute based in Shenzhen, China, which focuses on areas of nanoscience and nanoengineering.[10] As the inaugural Chair he oversaw the development of research collaborations with key Chinese universities such as Fudan University and Sichuan University. In 2012 he became Chair of UCLan Cyprus Ltd and provided the academic lead on the de novo creation of a private university in Larnaca, obtaining a licence to operate from the Ministry of Education with approval to initially run courses in business, languages, law, computing and mathematics.[11]

In 2013 he was selected to replace Martin Earwicker upon his retirement as Vice-Chancellor and Chief Executive of London South Bank University.[12] In 2014 he became Chair of MillionPlus, The Association for Modern Universities [13]

Public serviceEdit

He was appointed to an advisory committee for the appointment of Justice of the Peace by the Chancellor of the Duchy of Lancaster, a service which at the time came under the auspices of the Department for Constitutional Affairs. His work has tended to remain focused around the public understanding of science and education more broadly defined. He was appointed by the Department for Culture, Media and Sport as a Trustee for the Museum of Science and Industry in Manchester.[14] and in 2015 was appointed by the Prime Minister to the Board of the Science Museum Group.[15] He remains on the advisory board of the museum of science and industry. He has been a Trustee of both public and independent secondary schools and in 2009 he was appointed as an Ambassador to the Government Equalities Office to support work focused on increasing diversity in public life.


  1. ^ "Debrett's - The trusted source on British social skills, etiquette and style-Debrett's". Debretts.com. Archived from the original on 18 August 2013. Retrieved 12 January 2017.
  2. ^ "Professor David Phoenix took up the role of Vice-Chancellor at London South Bank University (LSBU) in 2014". London South Bank University. Retrieved 21 April 2017.
  3. ^ "Debrett's - The trusted source on British social skills, etiquette and style-Debrett's". Debretts.com. Archived from the original on 18 August 2013. Retrieved 12 January 2017.
  4. ^ "Professor David Phoenix took up the role of Vice-Chancellor at London South Bank University (LSBU) in 2014". London South Bank University. Retrieved 21 April 2017.
  5. ^ "David Andrew Phoenix (London South Bank University, London) on ResearchGate - Expertise: Biomedical Engineering, Biochemistry". Researchgate.net. Retrieved 12 January 2017.
  6. ^ "Bioactive Molecules Group | University of Central Lancashire, Preston, United Kingdom". Nanobiophys.wordpress.com. Retrieved 12 January 2017.
  7. ^ "No. 59446". The London Gazette (Supplement). 12 June 2010. p. 12.
  8. ^ "University announces July honours | University of Bolton". Bolton.ac.uk. 27 June 2013. Retrieved 12 January 2017.
  9. ^ "Archived copy". Archived from the original on 8 March 2008. Retrieved 29 October 2009.CS1 maint: archived copy as title (link)
  10. ^ [1][dead link]
  11. ^ Elledge, Jonn (6 August 2012). "Britain, where you can get a flat-pack campus". The Guardian.
  12. ^ Elmes, John. "LSBU to take orders from Phoenix | Times Higher Education (THE)". Times Higher Education. Retrieved 12 January 2017.
  13. ^ Morgan, John. "South Bank head Dave Phoenix to be new Million+ chair | Times Higher Education (THE)". Times Higher Education. Retrieved 12 January 2017.
  14. ^ "Archived copy" (PDF). Archived from the original (PDF) on 31 July 2009. Retrieved 29 October 2009.CS1 maint: archived copy as title (link)
  15. ^ "New Trustees to join Science Museum Group Board". Sciencemuseum.org.uk. 1 April 2015. Retrieved 12 January 2017.

External linksEdit

Academic offices
Preceded by
Martin Earwicker
Vice-Chancellor of
London South Bank University

Professional and academic associations
Preceded by
Michael Gunn
Chair of MillionPlus